Silverfin false 31/03/2023 21/02/2022 31/03/2023 Ms A Gupta 21/02/2022 Dr G Gupta 21/02/2022 Dr M Gupta 21/02/2022 Mr R Gupta 21/02/2022 13 November 2023 The principal activity of the Company during the financial period was that of general medical practice activities.

The company was incorporated on 21 February 2022 and the first financial statements cover the period from incorporation to 31 March 2023.
SC723848 2023-03-31 SC723848 bus:Director1 2023-03-31 SC723848 bus:Director2 2023-03-31 SC723848 bus:Director3 2023-03-31 SC723848 bus:Director4 2023-03-31 SC723848 core:CurrentFinancialInstruments 2023-03-31 SC723848 core:ShareCapital 2023-03-31 SC723848 core:RetainedEarningsAccumulatedLosses 2023-03-31 SC723848 bus:OrdinaryShareClass1 2023-03-31 SC723848 2022-02-21 2023-03-31 SC723848 bus:FullAccounts 2022-02-21 2023-03-31 SC723848 bus:SmallEntities 2022-02-21 2023-03-31 SC723848 bus:AuditExemptWithAccountantsReport 2022-02-21 2023-03-31 SC723848 bus:PrivateLimitedCompanyLtd 2022-02-21 2023-03-31 SC723848 bus:Director1 2022-02-21 2023-03-31 SC723848 bus:Director2 2022-02-21 2023-03-31 SC723848 bus:Director3 2022-02-21 2023-03-31 SC723848 bus:Director4 2022-02-21 2023-03-31 SC723848 bus:OrdinaryShareClass1 2022-02-21 2023-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: SC723848 (Scotland)

SKIN HEALTH SCOTLAND LTD

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 21 FEBRUARY 2022 TO 31 MARCH 2023
PAGES FOR FILING WITH THE REGISTRAR

SKIN HEALTH SCOTLAND LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL PERIOD FROM 21 FEBRUARY 2022 TO 31 MARCH 2023

Contents

SKIN HEALTH SCOTLAND LTD

BALANCE SHEET

AS AT 31 MARCH 2023
SKIN HEALTH SCOTLAND LTD

BALANCE SHEET (continued)

AS AT 31 MARCH 2023
31.03.2023
£
Current assets
Debtors 3 28,790
Cash at bank and in hand 147,388
176,178
Creditors: amounts falling due within one year 4 ( 58,685)
Net current assets 117,493
Total assets less current liabilities 117,493
Net assets 117,493
Capital and reserves
Called-up share capital 5 100
Profit and loss account 117,393
Total shareholders' funds 117,493

For the financial period ending 31 March 2023 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Skin Health Scotland Ltd (registered number: SC723848) were approved and authorised for issue by the Director on 13 November 2023. They were signed on its behalf by:

Dr G Gupta
Director
SKIN HEALTH SCOTLAND LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL PERIOD FROM 21 FEBRUARY 2022 TO 31 MARCH 2023
SKIN HEALTH SCOTLAND LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL PERIOD FROM 21 FEBRUARY 2022 TO 31 MARCH 2023
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.

General information and basis of accounting

Skin Health Scotland Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in Scotland. The address of the Company's registered office is 42/5 Gardner's Crescent, Edinburgh, EH3 8DG, Scotland, United Kingdom.

The financial statements have been prepared under the historical cost convention and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Reporting period length

The accounts represent the 13 month period from the date of incorporation to 31 March 2023.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for medical practice services provided in the normal course of business.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Impairment of assets

Assets are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Financial assets
An asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.

Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities
Basic financial liabilities, including creditors and loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

2. Employees

Period from
21.02.2022 to
31.03.2023
Number
Monthly average number of persons employed by the Company during the period, including directors 4

3. Debtors

31.03.2023
£
Trade debtors 27,106
Other debtors 1,684
28,790

4. Creditors: amounts falling due within one year

31.03.2023
£
Taxation and social security 55,685
Other creditors 3,000
58,685

5. Called-up share capital

31.03.2023
£
Allotted, called-up and fully-paid
100 Ordinary shares of £ 1.00 each 100

6. Related party transactions

Transactions with the entity's directors

31.03.2023
£
Amounts owed by directors 1,684